3.心臓核医学の現状と将来 : 1.核医学の今後はどう変化するか

概要

論文の詳細を見る
Nuclear cardiology has been established during the past decade. Cardiac imagings by ^<201>Tl or ^<99m>Tc-PYP and pool imagings by ^<99m>Tc-RBC are frequently used for diagnosis and evaluation of treatments. By these techniques, the information about blood flow of myocardium, myocardial damage and movement of ventricles can be obtained. In the past, information was two dimensional, however three dimensional information has been able to be obtained recently by using single photon emission computed tomography (SPECT) . Nuclear cardiology in the future depends on the development of new tracers, equipment and clinical application. The new tracers for myocardial blood flow such as ^<99m>Tc-Isonitrile or for myocardial damage such as ^<111>Indium Antimyosin will soon be available in U.S. Furthermore, tracers for metabolism of fat or glucose in myocardium are expected for diagnosis and evaluation for treatment of ischemic heart disease. Equipment for this field have not been completely developed yet. If evaluation of left ventricular function during daily actions could be carried out, it would be extremely valuable. New equipment for this purpose are now also available. Information obtained by nuclear are being used for diagnosis, management and its assessment. However, in the future these will also be utilized for risk stratification for rehabilitation, occupation and prognosis.
公益社団法人日本放射線技術学会の論文
1987-11-01